Xu D - Search Results

1

Retinoic acid ameliorates rheumatoid arthritis by attenuating inflammation and modulating macrophage polarization through MKP-1/MAPK signaling pathway.

Xin M, Jin H, Guo X, Zhao L, Li X, Xu D, Zheng L, Liu L. Xin M, et al. Among authors: xu d. Korean J Physiol Pharmacol. 2024 Nov 14. doi: 10.4196/kjpp.24.079. Online ahead of print. Korean J Physiol Pharmacol. 2024. PMID: 39539171 Free article.

2

Sesamin induces A549 cell mitophagy and mitochondrial apoptosis via a reactive oxygen species-mediated reduction in mitochondrial membrane potential.

Yang S, Li X, Dou H, Hu Y, Che C, Xu D. Yang S, et al. Among authors: xu d. Korean J Physiol Pharmacol. 2020 May 1;24(3):223-232. doi: 10.4196/kjpp.2020.24.3.223. Korean J Physiol Pharmacol. 2020. PMID: 32392913 Free PMC article.

3

Paeoniflorin ameliorates neuropathic pain-induced depression-like behaviors in mice by inhibiting hippocampal neuroinflammation activated via TLR4/NF-κB pathway.

Bai H, Chen S, Yuan T, Xu D, Cui S, Li X. Bai H, et al. Among authors: xu d. Korean J Physiol Pharmacol. 2021 May 1;25(3):217-225. doi: 10.4196/kjpp.2021.25.3.217. Korean J Physiol Pharmacol. 2021. PMID: 33859062 Free PMC article.

4

Cod (Gadus) skin collagen peptide powder reduces inflammation, restores mucosal barrier function, and inhibits fibrosis in dextran sodium sulfate-induced colitis in mice.

Guo X, Li X, Dong Y, Xie W, Jin T, Xu D, Liu L. Guo X, et al. Among authors: xu d. J Ethnopharmacol. 2023 Nov 15;316:116728. doi: 10.1016/j.jep.2023.116728. Epub 2023 Jun 3. J Ethnopharmacol. 2023. PMID: 37277083

5

FOXH1 promotes lung cancer progression by activating the Wnt/β-catenin signaling pathway.

Zhang J, Zhang X, Yang S, Bao Y, Xu D, Liu L. Zhang J, et al. Among authors: xu d. Cancer Cell Int. 2021 Jun 5;21(1):293. doi: 10.1186/s12935-021-01995-9. Cancer Cell Int. 2021. PMID: 34090445 Free PMC article.

6

Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K/AKT/GSK-3β signaling pathway and regulating intestinal flora distribution.

Wang X, Cao S, Huang Y, Li L, Xu D, Liu L. Wang X, et al. Among authors: xu d. Front Pharmacol. 2024 May 14;15:1396023. doi: 10.3389/fphar.2024.1396023. eCollection 2024. Front Pharmacol. 2024. PMID: 38808258 Free PMC article.

7

EBP1 promotes the malignant biological behaviors of kidney renal clear cell carcinoma through activation of p38/HIF-1α signaling pathway.

Meng H, Cao S, Tian S, Huo J, Li X, Xu D, Liu L. Meng H, et al. Among authors: xu d. Cancer Cell Int. 2024 Jul 24;24(1):261. doi: 10.1186/s12935-024-03442-x. Cancer Cell Int. 2024. PMID: 39049021 Free PMC article.

8

PLEKHA4 upregulation regulates KIRC cell proliferation through β‑catenin signaling.

Yue Y, An G, Cao S, Li X, Du L, Xu D, Jin T, Liu L. Yue Y, et al. Among authors: xu d. Mol Med Rep. 2025 Jan;31(1):30. doi: 10.3892/mmr.2024.13395. Epub 2024 Nov 14. Mol Med Rep. 2025. PMID: 39540374 Free PMC article.

9

The Relationship of the TLR9 and TLR2 Genetic Polymorphisms with Cervical Cancer Risk: a Meta-Analysis of Case-Control Studies.

Yang S, Liu L, Xu D, Li X. Yang S, et al. Among authors: xu d. Pathol Oncol Res. 2020 Jan;26(1):307-315. doi: 10.1007/s12253-018-0465-x. Epub 2018 Sep 13. Pathol Oncol Res. 2020. PMID: 30215163 Free article.

10

Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation.

Bao Y, Suvesh M, Li X, Bai X, Li H, Li X, Xu D, Liu L. Bao Y, et al. Among authors: xu d. Mol Carcinog. 2021 Apr;60(4):252-264. doi: 10.1002/mc.23288. Epub 2021 Feb 26. Mol Carcinog. 2021. PMID: 33634940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,850 results

Search Page

Filters